Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers.

Source:http://linkedlifedata.com/resource/pubmed/id/16471172

Download in:

View as

General Info

PMID
16471172